Mitochondrial Dysfunction in Ulcerative Colitis: Pathogenic Mechanisms and Novel Therapeutics
- 15 July 2026
- journal article
- review article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 40 (7) , e71021
Abstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease driven by a complex interplay of mitochondrial dysfunction. These defects impair energy production, increases oxidative stress, and disrupts immune balance. Here we review three therapeutic classes that target mitochondrial pathways: antioxidants, metabolic modulators, and microbiota‐directed strategies. In UC, mitochondrial dysfunction creates a self‐perpetuating cycle through metabolic‐immune crosstalk, the leakage of mitochondrial DNA, and the redistribution of cardiolipin. Moreover, the gut microbiota and mitochondria engage in bidirectional crosstalk that amplifies intestinal inflammation. Encouragingly, agents that restore mitochondrial function have shown therapeutic benefit in preclinical and early clinical studies. Notable examples include the mitochondria‐targeted antioxidant MitoQ (currently in a Phase 2b trial for UC), ClpP (caseinolytic protease P) activators that reprogram T‐cell metabolism, and engineered probiotics that deplete pro‐inflammatory succinate. This review synthesizes current evidence on mitochondrial dysfunction in UC, bridging molecular mechanisms, immune‐metabolic interactions, and emerging therapeutics to propose a new treatment paradigm centered on mitochondrial restoration.Keywords
This publication has 95 references indexed in Scilit:
- Myrtenol ameliorates ulcerative colitis by modulating ANXA1/PINK1/Parkin-mediated mitophagyJournal of Molecular Histology, 2025
- Sulfide Quinone Oxidoreductase Alleviates Acute Ulcerative Colitis by Regulating Mitochondrial DysfunctionMedcomm, 2025
- Potentilla anserina L. flavonoids ameliorate ulcerative colitis by modulating oxidative stress, intestinal microbiota dysbiosis, and inflammatory responses3 Biotech, 2025
- What Is Ulcerative Colitis?JAMA, 2024
- Licorice protects against ulcerative colitis via the Nrf2/PINK1‐mediated mitochondrial autophagyImmunity, Inflammation and Disease, 2022
- ROS-Responsive Berberine Polymeric Micelles Effectively Suppressed the Inflammation of Rheumatoid Arthritis by Targeting MitochondriaNano-Micro Letters, 2020
- Hesperidin modulates dextran sulfate sodium‐induced ulcerative colitis in rats: Targeting sphingosine kinase‐1‐ sphingosine 1 phosphate signaling pathway, mitochondrial biogenesis, inflammation, and apoptosisJournal of Biochemical and Molecular Toxicology, 2019
- Mitochondrial electron transport chain complex dysfunction in the colonic mucosa in ulcerative colitisInflammatory Bowel Diseases, 2012
- Mitochondrial respiratory chain in the colonic mucosal of patients with ulcerative colitisMolecular and Cellular Biochemistry, 2010
- Proteins that underlie neoplastic progression of ulcerative colitisProteomics – Clinical Applications, 2009